Greg Gibson

Karl Drlica, Ph.D. is Principal Investigator at the Public Health Research Institute Center of the UMDNJ-New Jersey Medical School. His laboratory focuses on fluoroquinolone action and resistance with M. tuberculosis and other bacteria, including approaches to slowing the enrichment and amplification of resistant bacterial subpopulations. Dr. David S. Perlin is a Principal Investigator at the Public Health Research Institute (PHRI) of the UMDNJ-New Jersey Medical School. His laboratory explores mechanisms of antifungal drug resistance, rapid detection of bloodstream pathogens in high-risk patients, discovery of novel molecules to combat tuberculosis, and the development of small animal models for respiratory pathogens. Paul Schoemaker is Research Director of the Mack Center for Technological Innovation at the Wharton School. He is founder and chairman of Decision Strategies International, Inc., a consulting and training firm specializing in strategic planning and executive development. He has written over 70 academic and applied papers, and co-author or editor of several books including Wharton On Managing Emerging Technologies, Winning Decisions, and Profiting from Uncertainty. Joyce A. Schoemaker is a biotech consultant and biology course instructor. Greg Gibson is Professor of Genetics at North Carolina State University in Raleigh, and of Integrative Biology at the University of Queensland, Australia. A leader in the new field of genomics, he serves on the editorial boards of PLoS Genetics, Current Biology, and Genetics. With Spencer V. Muse, he co-authored A Primer of Genome Science, one of the field’s leading textbooks. Anthony DePalma, currently writer-in-residence at Seton Hall University, spent 22 years as a reporter and foreign correspondent for The New York Times. After 9/11, he wrote many of the Times’ Pulitzer Prize-winning “Portraits of Grief,” and spent four years covering the environmental and health consequences of Ground Zero. A 2007 Emmy finalist for “Toxic Legacy,” in 2009 he won the prestigious Maria Moors Cabot Prize for distinguished international reporting.